Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries bioAffinity Technologies, Inc. - Common Stock (NQ: BIAF ) 2.000 UNCHANGED Streaming Delayed Price Updated: 3:59 PM EDT, Jun 14, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 441 Open 2.000 Bid (Size) 1.820 (5) Ask (Size) 2.190 (7) Prev. Close 2.000 Today's Range 2.000 - 2.000 52wk Range 0.9548 - 3.620 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News bioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung Tests June 12, 2024 From bioAffinity Technologies, Inc. Via Business Wire BIAF Stock Earnings: bioAffinity Technologies Reported Results for Q1 2024 May 15, 2024 bioAffinity Technologies just reported results for the first quarter of 2024. Via InvestorPlace Performance YTD +18.34% +18.34% 1 Month -11.50% -11.50% 3 Month -6.10% -6.10% 6 Month +42.86% +42.86% 1 Year +19.05% +19.05% More News Read More bioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory Volumes May 15, 2024 From bioAffinity Technologies, Inc. Via Business Wire bioAffinity Technologies News Update May 02, 2024 From bioAffinity Technologies, Inc. Via Business Wire bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth April 24, 2024 From bioAffinity Technologies, Inc. Via Business Wire bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening April 09, 2024 From bioAffinity Technologies, Inc. Via Business Wire 12 Health Care Stocks Moving In Friday's Intraday Session April 05, 2024 Via Benzinga BIAF Stock Earnings: bioAffinity Technologies Reported Results for Q4 2023 April 01, 2024 Via InvestorPlace bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results April 01, 2024 From bioAffinity Technologies, Inc. Via Business Wire 12 Health Care Stocks Moving In Monday's Intraday Session March 11, 2024 Via Benzinga Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session March 11, 2024 Via Benzinga Exposures Product Safety bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement March 08, 2024 From bioAffinity Technologies, Inc. Via Business Wire Nasdaq Gains 100 Points; Campbell Soup Earnings Top Views March 06, 2024 Via Benzinga Topics Stocks Exposures US Equities Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session March 06, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session March 06, 2024 Via Benzinga Why BioAffinity Technologies (BIAF) Shares Are Down 50% March 06, 2024 Via Benzinga bioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement March 06, 2024 From bioAffinity Technologies, Inc. Via Business Wire bioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lung March 05, 2024 From bioAffinity Technologies, Inc. Via Business Wire Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session March 05, 2024 Via Benzinga bioAffinity Technologies News Update February 21, 2024 From bioAffinity Technologies, Inc. Via Business Wire Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical Practice February 06, 2024 From bioAffinity Technologies, Inc. Via Business Wire bioAffinity Technologies In The News January 30, 2024 From bioAffinity Technologies, Inc. Via Business Wire bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer January 23, 2024 From bioAffinity Technologies Via Business Wire bioAffinity Technologies In the News January 08, 2024 From bioAffinity Technologies Via Business Wire bioAffinity Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV January 05, 2024 Via ACCESSWIRE Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
